According to the latest data from the Hong Kong Stock Exchange, on October 30, Lazard Asset Management LLC increased its holdings of Sinopharm (SEHK: 01099) by 5,397,677 shares at HK$16.19 per share, for a total amount of approximately HK$87.3884 million.
Following the increase, its latest shareholding stands at approximately 191 million shares, with the latest shareholding ratio at 14.26%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments